Corporate Governance:

Good corporate governance practices are integral to all of Al Nahda’s business activities. Al Nahda recognises that corporate governance is essential to earn the confidence of its shareholders, patients, employees, community, medical professionals, suppliers, payors and all other stakeholders. Al Nahda is committed to conducting business with integrity, openness, transparency and accountability.

Al Nahda’s Board of Directors is accountable to all stakeholders for comprehensive and accurate financial reporting, achievement of strategic goals, and running its business in compliance with regulations.

Al Nahda complies with the requirements of the UK Corporate Governance Code published in September 2012 by the Financial Reporting Council, save that::

  • (i) the number of Independent Non-Executive Directors, excluding the Chairman, shall be less than half the Board.
  • (ii) Faisal Belhoul*, who is a member of the Remuneration Committee, is not an Independent Non-Executive Director.
  • (iii) Ian Tyler*, who is Chairman of the Board, is also the chairman of the Remuneration Committee.
  • (iv) Ian Tyler*, is a member of the Audit Committee.